Literature DB >> 25119506

Unified theory on the pathogenesis of Randall's plaques and plugs.

Saeed R Khan1, Benjamin K Canales.   

Abstract

Kidney stones develop attached to sub-epithelial plaques of calcium phosphate (CaP) crystals (termed Randall's plaque) and/or form as a result of occlusion of the openings of the Ducts of Bellini by stone-forming crystals (Randall's plugs). These plaques and plugs eventually extrude into the urinary space, acting as a nidus for crystal overgrowth and stone formation. To better understand these regulatory mechanisms and the pathophysiology of idiopathic calcium stone disease, this review provides in-depth descriptions of the morphology and potential origins of these plaques and plugs, summarizes existing animal models of renal papillary interstitial deposits, and describes factors that are believed to regulate plaque formation and calcium overgrowth. Based on evidence provided within this review and from the vascular calcification literature, we propose a "unified" theory of plaque formation-one similar to pathological biomineralization observed elsewhere in the body. Abnormal urinary conditions (hypercalciuria, hyperoxaluria, and hypocitraturia), renal stress or trauma, and perhaps even the normal aging process lead to transformation of renal epithelial cells into an osteoblastic phenotype. With this de-differentiation comes an increased production of bone-specific proteins (i.e., osteopontin), a reduction in crystallization inhibitors (such as fetuin and matrix Gla protein), and creation of matrix vesicles, which support nucleation of CaP crystals. These small deposits promote aggregation and calcification of surrounding collagen. Mineralization continues by calcification of membranous cellular degradation products and other fibers until the plaque reaches the papillary epithelium. Through the activity of matrix metalloproteinases or perhaps by brute physical force produced by the large sub-epithelial crystalline mass, the surface is breached and further stone growth occurs by organic matrix-associated nucleation of CaOx or by the transformation of the outer layer of CaP crystals into CaOx crystals. Should this theory hold true, developing an understanding of the cellular mechanisms involved in progression of a small, basic interstitial plaque to that of an expanding, penetrating plaque could assist in the development of new therapies for stone prevention.

Entities:  

Mesh:

Year:  2014        PMID: 25119506      PMCID: PMC4373525          DOI: 10.1007/s00240-014-0705-9

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  141 in total

Review 1.  Molecular determinants of extracellular matrix mineralization in bone and blood vessels.

Authors:  Monzur Murshed; Marc D McKee
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

Review 2.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

3.  Changes in urine macromolecular composition during processing.

Authors:  S Maslamani; P A Glenton; S R Khan
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

4.  Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.

Authors:  M Zeisberg; G Bonner; Y Maeshima; P Colorado; G A Müller; F Strutz; R Kalluri
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 5.  Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles.

Authors:  Vivek Kumar; Gerard Farell; Shihui Yu; Sean Harrington; Lorraine Fitzpatrick; Ewa Rzewuska; Virginia M Miller; John C Lieske
Journal:  J Investig Med       Date:  2006-11       Impact factor: 2.895

6.  Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.

Authors:  F Atmani; P A Glenton; S R Khan
Journal:  Urol Res       Date:  1998

Review 7.  Stress oxidative: nephrolithiasis and chronic kidney diseases.

Authors:  S R Khan
Journal:  Minerva Med       Date:  2013-02       Impact factor: 4.806

Review 8.  New insights into the pathogenesis of renal calculi.

Authors:  Herman Singh Bagga; Thomas Chi; Joe Miller; Marshall L Stoller
Journal:  Urol Clin North Am       Date:  2012-10-23       Impact factor: 2.241

Review 9.  Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification.

Authors:  Willi Jahnen-Dechent; Cora Schäfer; Markus Ketteler; Marc D McKee
Journal:  J Mol Med (Berl)       Date:  2007-12-15       Impact factor: 4.599

Review 10.  Physiopathology and etiology of stone formation in the kidney and the urinary tract.

Authors:  Andrew P Evan
Journal:  Pediatr Nephrol       Date:  2009-02-07       Impact factor: 3.714

View more
  41 in total

Review 1.  Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

2.  Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan
Journal:  Urolithiasis       Date:  2021-01-23       Impact factor: 3.436

3.  Novel porcine model for calcium oxalate stone formation.

Authors:  Brandon P Trojan; Sara J Trojan; Andrew Navetta; Bryce Staches; Bryan Sutton; Stephanie Filleur; Thomas Nelius
Journal:  Int Urol Nephrol       Date:  2017-07-13       Impact factor: 2.370

4.  Randall's plaque in stone formers originates in ascending thin limbs.

Authors:  Andrew P Evan; Fredric L Coe; James Lingeman; Sharon Bledsoe; Elaine M Worcester
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

5.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

Review 6.  Histological aspects of the "fixed-particle" model of stone formation: animal studies.

Authors:  Saeed R Khan
Journal:  Urolithiasis       Date:  2016-11-28       Impact factor: 3.436

Review 7.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

Review 8.  Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.

Authors:  Allison L O'Kell; David C Grant; Saeed R Khan
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

9.  Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms.

Authors:  Ingo Sethmann; Gunnar Wendt-Nordahl; Thomas Knoll; Frieder Enzmann; Ludwig Simon; Hans-Joachim Kleebe
Journal:  Urolithiasis       Date:  2016-10-01       Impact factor: 3.436

Review 10.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.